#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Behcet's syndrome Urea cycle disorder Loss of consciousness Duchenne muscular dystrophy gene carrier Ovarian cancer stage III Thyroid cancer metastatic Neuroendocrine cell hyperplasia of infancy Marfan's syndrome Leukaemia Leiomyosarcoma metastatic Pleomorphic leiomyosarcoma Cytokine release syndrome Ependymoma Pouchitis Haemophilia B without inhibitors More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III – Treatment Glycogen storage disease type I – Diagnostics Leukoencephalopathy – Treatment Prader-Willi syndrome – Trials in Disease Glycogen storage disease type V – Life with Disease Factor IX deficiency Synovial sarcoma – Treatment Piriformis syndrome – Diagnostics Turner’s syndrome – Basic Information KBG syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TRIMIPRAMINE MALEATE Vonafexor Brimonidine Nilutamide Pf-06835375 Aptamer-4Ft Bevacizumab Zirconium Zr-89 Bisoprolol Fumarate Netupitant Sodium Nitroprusside Dihydrate Fosaprepitant Ag13909 Prx005 ADX-324 Pemafibrate Doxycycline Hyclate Lapatinib Dazucorilant LIGUFALIMAB Rbl012.2 More therapies…

    Learn about Your Condition

    Encephalitis Japanese B Menopause Skin papilloma Colour blindness Metachromatic leukodystrophy Cervix carcinoma stage IV Craniosynostosis Staphylococcal infection Asplenia Dermatitis atopic Angina pectoris Post-traumatic stress disorder Spinal muscular atrophy Post procedural hypotension Endometrial cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neuralgia

  • Study on the Effects of THC and CBD Oral Solution for Chronic Neuropathic Pain in Multiple Sclerosis Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Neuralgia
    • Multiple sclerosis
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Portugal
  • Study on Psilocybin for Relieving Chronic Neuropathic Pain in Patients with Chemotherapy-Induced Peripheral Neuropathy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuralgia
    • Neuropathy peripheral
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    • Oxazepam
    The Netherlands
  • Study Comparing Serratus Plane Block, Capsaicin, and Botulinum Toxin Type A for Chronic Pain in Post-Mastectomy Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Post breast therapy pain syndrome
    • Neuralgia
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Nefopam Hydrochloride
    • Clonidine Hydrochloride
    France
  • Study on the Effects of THC 2% Oil for Patients with Chronic Neuropathic Pain

    Recruiting

    2 1
    Investigated Diseases:
    • Neuralgia
    Investigated Drugs:
    • Dronabinol
    The Netherlands
  • Study on Capsaicin Patch for Treating Chronic Neuropathic Pain in Children Aged 12-17

    Recruiting

    3 1 1
    Investigated Drugs:
    • Tramadol
    • Capsaicin
    France
  • Study on the Effect of Pregabalin on Sleep and Pain in Patients with Neuropathic Pain

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuralgia
    Investigated Drugs:
    • Pregabalin
    Finland
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!